A model of the acid sphingomyelinase phosphoesterase domain based on its remote structural homolog purple acid phosphatase

Protein Science

Volumn 13, Issue 12, 2004, Pages 3172-3186

  Seto, Marian ^a   Whitlow, Marc ^a   McCarrick, Margaret A ^b   Srinivasan, Subha ^c   Zhu, Ying ^a   Pagila, Rene ^a   Mintzer, Robert ^a   Light, David ^a   Johns, Anthony ^a   Meurer Ogden, Janet A ^a  

^a BAYER AG   (Germany)

^b CELGENE CORPORATION   (United States)

^c Jivan Biologics Inc   (United States)

Author keywords

Acid sphingomyelinase; Phosphoesterase; Purple acid phosphatase; Structure predictions; Threading

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ASPARAGINE; ASPARTIC ACID; HISTIDINE; METAL DERIVATIVE; OXYGEN; PHOSPHORUS; PHOSPHORYLCHOLINE; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE;

AMINO ACID SEQUENCE; ARTICLE; CATALYSIS; CHEMICAL BOND; HUMAN; MAMMAL; MISSENSE MUTATION; MODEL; NIEMANN PICK DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN HYDROLYSIS; PROTEIN MOTIF; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; STRUCTURAL HOMOLOGY; STRUCTURE ANALYSIS;

ACID PHOSPHATASE; AMINO ACID SEQUENCE; ANIMALS; CATALYTIC DOMAIN; CRYSTALLOGRAPHY, X-RAY; GLYCOPROTEINS; HUMANS; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, SECONDARY; RATS; SEQUENCE ALIGNMENT; SPHINGOMYELIN PHOSPHODIESTERASE; STRUCTURAL HOMOLOGY, PROTEIN;

MAMMALIA;

EID: 9344221645     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1110/ps.04966204     Document Type: Article

References (70)

1. Alexandrov, N.N., Nussinov, R., and Zimmer, R.M. 1996. Fast protein fold recognition via sequence to structure alignment and contact capacity potentials. Pac. Symp. Biocomput. 53-73.
2. Altschul, S.F., Gish, W., Miller, W., Myers, E.W., and Lipman, DJ. 1990. Basic local alignment search tool. J. Mol. Biol. 215: 403-410.
3. Altschul, S.F., Madden, T.L.. Schaffer, A.A., Zhang, J., Zhang, Z., Miller, W., and Lipman, D. J. 1997. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res. 25: 3389-3402.
4. Bairoch, A. and Boeckmann, B. 1994. The SWISS-PROT protein sequence data bank: Current status. Nucleic Acids Res. 22: 3578-3580.
5. Benson, D.A., Karsch-Mizrachi, I., Lipman, D.J., Ostell, J., Rapp, B.A., and Wheeler, D.L. 2000. GenBank. Nucleic Acids Res. 28: 15-18.
6. Berman, H.M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T.N., Weissig, H., Shindyalov, I.N., and Bourne, P.E. 2000. The Protein Data Bank. Nucleic Acids Res. 28: 235-242.
7. Besley, G.T., Hoogeboom, A.J., Hoogeveen, A., Kleijer, W.J., and Galjaard, H. 1980. Somatic cell hybridization studies showing different gene mutations in Niemann-Pick variants. Hum. Genet. 54: 409-412.
8. Callahan, J.W. and Khalil, M. 1976. Sphingomyelinases and the genetic defects in Niemann-Pick disease. Adv. Exp. Med. Biol. 68: 367-378.
9. Callahan, J.W., Jones, C.S., Davidson, D.J., and Shankaran, P. 1983. The active site of lysosomal sphingomyelinase: Evidence for the involvement of hydrophobic and ionic groups. J. Neurosci. Res. 10: 151-163.
10. Denessiouk, K.A. and Johnson, M.S. 2000. When fold is not important: A common structural framework for adenine and AMP binding in 12 unrelated protein families. Proteins 38: 310-326.
11. Dietrich, M., Munstermann, D., Suerbaum, H., and Witzel, H. 1991. Purple acid phosphatase from bovine spleen. Interactions at the active site in relation to the reaction mechanism. Eur. J. Biochem. 199: 105-113.
12. Eddy, S.R. 1998. Profile hidden Markov models. Bioinformatics 14: 755-763.
13. Egloff, M.P., Cohen, P.T., Reinemer, P., and Barford, D. 1995. Crystal structure of the catalytic subunit of human protein phosphatase 1 and its complex with tungstate. J. Mol. Biol. 254: 942-959.
14. Ferlinz, K., Hurwitz, R., Weiler, M., Suzuki, K., Sandhoff, K., and Vanier, M.T. 1995. Molecular analysis of the acid sphingomyelinase deficiency in a family with an intermediate form of Niemann-Pick disease. Am. J. Hum. Genet. 56: 1343-1349.
15. Frishman, D. and Argos, P. 1997. Seventy-five percent accuracy in protein secondary structure prediction. Proteins 27: 329-335.
16. Goni, P.M. and Alonso, A. 2002. Sphingomyelinases: Enzymology and membrane activity. FEBS Letters 531: 38-46.
17. Guddat, L.W., McAlpine, A.S., Hume, D., Hamilton, S., de Jersey, J., and Martin, J.L. 1999. Crystal structure of mammalian purple acid phosphatase. Structure Fold. Des. 7: 757-767.
18. He, X., Miranda, S.R., Xiong, X., Dagan, A., Gatt, S., and Schuchman, E.H. 1999. Characterization of human acid sphingomyelinase purified from the media of overexpressing Chinese hamster ovary cells. Biochim. Biophys. Acta 1432: 251-264.
19. Jones, D.T. 1999. Protein secondary structure prediction based on position-specific scoring matrices. J. Mol Biol 292: 195-202.
20. Kelley, L.A., MacCallum, R.M., and Sternberg, M.J. 2000. Enhanced genome annotation using structural profiles in the program 3D-PSSM. J. Mol. Biol. 299: 499-520.
21. King, R.D. and Sternberg, M.J. 1996. Identification and application of the concepts important for accurate and reliable protein secondary structure prediction. Protein Sci. 5: 2298-2310.
22. Klabunde, T., Strater, N., Frohlich, R., Witzel, H., and Krebs, B. 1996. Mechanism of Fe(III)-Zn(II) purple acid phosphatase based on crystal structures. J. Mol Biol 259: 737-748.
23. Knöfel, T. and Strater, N. 1999. X-ray structure of the Escherichia coli periplasmic 5′-nucleotidase containing a dimetal catalytic site. Nat. Struct. Biol 6: 448-453.
24. Kolodny, E.H. 2000. Niemann-Pick disease. Curr. Opin. Hematol. 7: 48-52.
25. Koonin, E.V. 1994. Conserved sequence pattern in a wide variety of phosphoesterases. Protein Sci. 3: 356-358.
26. Lansmann, S., Schuette, C.G., Bartelsen, O., Hoernschemeyer, J., Linke, T., Weisgerber, J., and Sandhoff, K. 2003. Human acid sphingomyelinase: Assignment of the disulfide bond pattern. Eur. J. Biochem. 270: 1076-1088.
27. Levade, T., Salvayre, R., and Douste-Blazy, L. 1986. Sphingomyelinases and Niemann-Pick disease. J. Clin. Chem. Clin. Biochem. 24: 205-220.
28. Levran, O., Desnick, R.J., and Schuchman, E.H. 1992. Identification and expression of a common missense mutation (L302P) in the acid sphingomyelinase gene of Ashkenazi Jewish type A Niemann-Pick disease patients. Blood 80: 2081-2087.
29. Lüthy, R., Bowie, J.U., and Eisenberg, D. 1992. Assessment of protein models with three-dimensional profiles. Nature 356: 83-85.
30. Marathe, S., Schissel, S.L., Yellin, M.J., Beatini, N., Mintzer, R., Williams, K.J., and Tabas, I. 1998. Human vascular endothelial cells are a rich and regulatable source of secretory sphingomyelinase. Implications for early atherogenesis and ceramide-mediated cell signaling. J. Biol. Chem. 273: 4081-4088.
31. Marathe, S., Kuriakose, G., Williams, K. J., and Tabas, I. 1999. Sphingomyelinase, an enzyme implicated in atherogenesis, is present in atherosclerotic lesions and binds to specific components of the subendothelial extracellular matrix. Arlerioscler. Thromb. Vasc. Biol. 19: 2648-2658.
32. Marathe, S., Miranda, S.R., Devlin, C., Johns, A., Kuriakose, G., Williams, K.J., Schuchman, E.H., and Tabas, I. 2000. Creation of a mouse model for non-neurological (type B) Niemann-Pick disease by stable, low level expression of lysosomal sphingomyelinase in the absence of secretory sphingomyelinase: Relationship between brain intra-lysosomal enzyme activity and central nervous system function. Hum. Mol. Genet. 9: 1967-1976.
33. Matsuo, Y., Yamada, A., Tsukamoto, K., Tamura, H., Ikezawa, H., Nakamura, H., and Nishikawa, K. 1996. A distant evolutionary relationship between bacterial sphingomyelinase and mammalian DNase 1. Protein Sci. 5: 2459-2467.
34. Mueller, E.G., Crowder, M.W., Averill. B.A., and Knowles. J.R. 1993. Purple acid phosphatase: Diiron enzyme that catalyzes a direct phospho group transfer to water. J. Am. Chem. Soc. 115: 2974-2975.
35. Murzin, A.G., Brenner, S.E., Hubbard, T., and Chothia, C. 1995. SCOP: A structural classification of proteins database for the investigation of sequences and structures. J. Mol. Biol. 247: 536-540.
36. Orengo, C.A., Michie, A.D., Jones, S., Jones, D.T., Swindells, M.B., and Thornton, J.M. 1997. CATH - A hierarchic classification of protein domain structures. Structure 5: 1093-1108.
37. Pearson, W.R. 1990. Rapid and sensitive sequence comparison with FASTP and FASTA. Methods Enzymol. 183: 63-98.
38. Pepys, M.B., Dash, A.C., Fletcher, T.C., Richardson, N., Munn, E.A., and Feinstein, A. 1978. Analogues in other mammals and in fish of human plasma proteins, C-reactive protein and amyloid P component. Nature 273: 168-170.
39. Perisic, O., Paterson, H.F., Mosedale, G., Lara-Gonzalez, S., and Williams, R.L. 1999. Mapping the phospholipid-binding surface and translocation determinants of the C2 domain from cytosolrc phospholipase A2. J. Biol. Chem. 274: 14979-14987.
40. Ponting, C.P. 1994. Acid sphingomyelinase possesses a domain homologous to its activator proteins: Saposins B and D. Protein Sci. 3: 359-361.
41. Quintern, L.E., Weitz, G., Nehrkorn, H., Tager, J.M., Schram, A.W., and Sandhoff, K. 1987. Acid sphingomyelinase from human urine: Purification and characterization. Biochim. Biophyx. Acta. 922: 323-336.
42. Rodrigues-Lima, F., Fensome, A.C., Josephs, M., Evans, J., Veldman, R.J., and Katan, M. 2000. Structural requirements for catalysis and membrane targeting of mammalian enzymes with neutral sphingomyelinase and lysophospholipid phospholipase C activities. Analysis by chemical modification and site-directed mutagenesis. J. Biol. Chem. 275: 28316-28325.
43. Rost, B. and Sander, C. 1993. Prediction of protein secondary structure at better than 70% accuracy. J. Mol. Biol. 232: 584-599.
44. Schissel, S.L., Schuchman, E.H., Williams, K.J., and Tabas, I. 1996a. Zn2+-stimulated sphingomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene. J. Biol. Chem. 271: 18431-18436.
45. Schissel, S.L., Tweedie-Hardman, J., Rapp, J.H., Graham, G., Williams, K.J., and Tabas, I. 1996b. Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins. J. Clin. Invest. 98: 1455-1464.
46. Schissel, S.L., Jiang, X., Tweedie-Hardman, J., Jeong, T., Camejo, E.H., Najib, J., Rapp, J.H., Williams, K.J., and Tabas, I. 1998a. Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development. J. Biol. Chem. 273: 2738-2746.
47. Schissel, S.L., Keesler, G.A., Schuchman, E.H., Williams, K.J., and Tabas, I. 1998b. The cellular trafficking and zinc dependence of secretory and lysosomal sphingomyelinase. two products of the acid sphingomyelinase gene. J. Biol. Chem. 273: 18250-18259.
48. Schmitt, S., Kuhn, D., and Klebe, G. 2002. A new method to detect related function among proteins independent of sequence and fold homology. J. Mol. Biol. 323: 387-406.
49. Schuchman, E.H. and Miranda, S.R. 1997. Niemann-Pick disease: Mutation update, genotype/phenotype correlations, and prospects for genetic testing. Genet. Test. 1: 13-19.
50. Schuchman, E.H., Suchi, M., Takahashi, T., Sandhoff, K., and Desnick, R.J. 1991. Human acid sphingomyelinase. Isolation, nucleotide sequence and expression of the full-length and alternatively spliced cDNAs. J. Biol Chem. 266: 8531-8539.
51. Schwalbe, R.A., Dahlback, B., Coe, J.E., and Nelsestuen, G.L. 1992. Pentraxin family of proteins interact specifically with phosphorylcholine and/or phosphorylethanolamine, Biochemistry 31: 4907-4915.
52. Sikora, J., Pavlu-Pereira, H., Elleder, M., Roelofs, H., and Wevers, R.A. 2003. Seven novel acid sphingomyelinase gene mutations in Niemann-Pick type A and B patients. Ann. Hum. Genet. 67: 63-70.
53. Simonaro, C.M., Desnick, R.J., McGovern, M.M., Wasserstein, M.P., and Schuchman, E.H. 2002. The demographics and distribution of type B Niemann-Pick disease: Novel mutations lead to new genotype/phenotype correlations. Am. J. Hum. Genet. 71: 1413-1419.
54. Smith, T.F. and Waterman, M.S. 1981. Identification of common molecular subsequences. J. Mol Biol. 147: 195-197.
55. Sonnhammer, E.L., Eddy, S.R., Birney, E., Bateman, A., and Durbin, R. 1998. Pfam: Multiple sequence alignments and HMM-profiles of protein domains. Nucleic Acids Res. 26: 320-322.
56. Sperl, W., Bart, G., Vanier, M.T., Christomanou, H., Baldissera, I., Steichen-Gersdorf, E., and Paschke, E. 1994. A family with visceral course of Niemann-Pick disease, macular halo syndrome and low sphingomyelin degradation rate. J. Inherit. Metab. Dis. 17: 93-103.
57. Swairjo, M.A., Concha, N.O., Kaetzel, M.A., Dedman, J.R., and Seaton, B.A. 1995. Ca(2+)-bridging mechanism and phospholipid head group recognition in the membrane-binding protein annexin V. Nat. Struct. Biol. 2: 968-974.
58. Tabas, I. 1999. Secretory sphingomyelinase. Chem. Phys. Lipids 102: 123-130.
59. Tabas, I., Li, Y., Brocia, R.W., Xu, S.W., Swenson, T.L., and Williams, K.J. 1993. Lipoprotein lipase and sphingomyelinase synergistically enhance the association of atherogenic lipoproteins with smooth muscle cells and extracellular matrix. A possible mechanism for low density lipoprotein and lipoprotein(a) retention and macrophage foam cell formation. J. Biol. Chem. 268: 20419-20432.
60. Takahashi, T., Suchi, M., Desnick, R.J., Takada, G., and Schuchman, E.H. 1992. Identification and expression of five mutations in the human acid sphingomyelinase gene causing types A and B Niemann-Pick disease. Molecular evidence for genetic heterogeneity in the neuronopathic and non-neuronopathic forms. J. Biol. Chem. 267: 12552-12558.
61. Takahashi, T., Akiyama, K., Tomihara, M., Tokudome, T., Nishinomiya, F., Tazawa, Y., Horinouchi, K., Sakiyama, T., and Takada, G. 1997. Heterogeneity of liver disorder in type B Niemann-Pick disease. Hum. Pathol. 28: 385-388.
62. Thompson, D., Pepys, M.B., and Wood, S.P. 1999. The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure Fold. Des. 7: 169-177.
63. Thompson, J.D., Higgins, D.G., and Gibson, T.J. 1994. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22: 4673-4680.
64. Uppenberg, J., Lindqvist, F., Svensson, C., Ek-Rylander, B., and Andersson, G. 1999. Crystal structure of a mammalian purple acid phosphatase. J. Mol. Biol. 290: 201-211.
65. Verdaguer, N., Corbalan-Garcia, S., Ochoa, W.F., Fita, I., and Gomez-Fernandez, J.C. 1999. Ca(2+) bridges the C2 membrane-binding domain of protein kinase Ca directly to phosphatidylserine. EMBO J. 18: 6329-6338.
66. Vincent, J.B. and Averill, B.A. 1990. An enzyme with a double identity: Purple acid phosphatase and tartrate-resistant acid phosphatase. FASEB J. 4: 3009-3014.
67. Weston, S.A., Lahm, A., and Suck, D. 1992. X-ray structure of the DNase I-d(GGTATACC)2 complex at 2.3 A resolution. J. Mol. Biol. 226: 1237-1256.
68. Williams, K.J. and Tabas, I. 1995. The response-to-retention hypothesis of early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 15: 551-561.
69. Yamanaka, T. and Suzuki, K. 1982. Acid sphingomyelinase of human brain: Purification to homogeneity. J. Neurochem. 38: 1753-1764.
70. Zhuo, S., Clemens, J.C., Stone, R.L., and Dixon, J.E. 1994. Mutational analysis of a Ser/Thr phosphatase. Identification of residues important in phosphoesterase substrate binding and catalysis. J. Biol. Chem. 269: 26234-26238.